Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Carrie Lachance, the President and Chief Executive Officer of InfuSystem Holdings, Inc. (NASDAQ: INFU), has expanded her ownership stake in the company through two distinct open market transactions. These purchases occurred in May 2026, signaling a direct investment by top leadership at a time when the company's stock has faced recent downward pres…
A recent regulatory filing with the Securities and Exchange Commission has revealed that Paul Andrew Gendron, a Director at InfuSystem Holdings, Inc. (NASDAQ: INFU), has increased his position in the company through a purchase of common stock. The transaction occurred on May 8, 2026, involving the acquisition of 5,000 shares. This move highlights i…
Billy J Jr. Lyons, a member of the board of directors at Old Second Bancorp Inc. (NASDAQ: OSBC), has increased his stake in the company through a recent purchase of common stock. The transaction occurred on May 11, 2026, signaling continued direct investment from within the organization's leadership. This move comes as the bank navigates a period c…
Skyward Specialty Insurance Group appoints Melissa Goto as President of E&S Brokerage and Inland Marine divisions, aiming to leverage her 25+ years of underwriting and leadership expertise to enhance strategic development and market position in specialty property and casualty insurance.
Aquestive Therapeutics has completed a new $150 million debt financing agreement with Oaktree Capital Management, providing improved financial flexibility by reducing near-term principal repayments and lowering interest rates. This capital structure enhancement is aimed at supporting the potential FDA approval and launch of Anaphylm, a novel sublin…
Geron Corporation announced the presentation of the first real-world evidence study of RYTELO (imetelstat) in patients with lower-risk myelodysplastic syndromes (LR-MDS) at the EHA 2026 Congress. The study, conducted at Moffitt Cancer Center, demonstrated safety and clinical efficacy consistent with the Phase 3 IMerge trial, including in heavily tr…
Agios Pharmaceuticals has submitted a supplemental New Drug Application (sNDA) to the FDA seeking accelerated approval for mitapivat, an oral pyruvate kinase activator, for the treatment of sickle cell disease. The submission follows FDA agreement on a confirmatory trial designed to demonstrate the drug's clinical benefit in reducing transfusion bu…
Parsons Corporation said it secured a multiple award task order from the U.S. Air Force and the 75th Civil Engineer Group at Hill Air Force Base, a program worth up to $136 million that covers architect-engineer services across the installation and spans an 8.5-year performance window. The announcement coincided with a 1.9% premarket uptick in the …
Analysts say the Beijing summit between President Donald Trump and President Xi Jinping is more likely to reinforce a fragile détente than to produce sweeping new agreements. Modest, market-oriented deliverables - such as Chinese purchases of U.S. farm goods and aircraft, eased rare earth restrictions, or the formation of a bilateral trade board - …
Star Bulk Carriers Corp., a major global dry bulk shipping company, has announced the results of its 2026 Annual Meeting of Shareholders held in Athens, Greece. The company reported the re-election of key directors and the appointment of Deloitte Certified Public Accountants S.A. as its independent auditors for the fiscal year 2026. Star Bulk highl…
Cogent Biosciences announced multiple presentations at the European Hematology Association (EHA) 2026 Congress, including pivotal oral presentation data from the APEX trial of bezuclastinib in Advanced Systemic Mastocytosis and preclinical data for their JAK2 V617F inhibitor program. These presentations underscore the company's progress in developi…
Disc Medicine announced multiple presentations at the European Hematology Association (EHA) 2026 Congress, including an oral presentation of phase 2 RALLY-MF trial data for DISC-0974 targeting anemia in myelofibrosis patients. The company also highlighted updates on bitopertin in erythropoietic protoporphyria (EPP) and ongoing trials for polycythem…
Caribou Biosciences announced that two of its investigational allogeneic CAR-T cell therapies, vispa-cel and CB-011, will be featured in oral presentations at the 2026 European Hematology Association Annual Meeting. These presentations will share updated clinical trial data demonstrating the therapies' potential in treating relapsed or refractory B…
Beam Therapeutics announced it will present updated Phase 1/2 clinical trial data for ristoglogene autogetemcel (risto-cel), an investigational gene-edited cell therapy aimed at treating sickle cell disease (SCD). The data underscores risto-cel's potential to restore red blood cell health and improve disease pathology by inducing fetal hemoglobin p…
Agios Pharmaceuticals announced new detailed data presentations of mitapivat at the 31st European Hematology Association Congress (EHA 2026). Results from the pivotal RISE UP Phase 3 trial in sickle cell disease demonstrate significant hemoglobin improvements and anti-hemolytic effects. Additional positive long-term data from ENERGIZE trials in tha…
Alpha Compute Corp. announced a definitive two-year lease agreement worth $32.2 million with an unnamed leading AI laboratory for a dedicated deployment of 504 NVIDIA B200 GPUs at its Canadian data center. This contract delivers $16.1 million in annual recurring revenue and marks the company's first enterprise-scale GPUaaS deal, signaling strong de…
Cellectis announced upcoming presentations of Phase 1 clinical trial data for its allogeneic CAR-T therapies lasme-cel and eti-cel at the European Hematology Association Annual Congress 2026. The data highlight promising safety and efficacy in treating relapsed or refractory B-cell malignancies, supporting ongoing pivotal Phase 2 trials with interi…
Moleculin Biotech announced that an independent review by the Cleveland Clinic of pooled data from five clinical trials demonstrates that Annamycin, their next-generation anthracycline for relapsed/refractory acute myeloid leukemia (R/R AML), does not cause clinically significant cardiotoxicity even at cumulative doses exceeding conventional anthra…
21shares has introduced two innovative ETFs on the NASDAQ: the 21shares Hyperliquid ETF (THYP) providing direct spot exposure to HYPE token with staking rewards, and the 21shares 2x Long Hyperliquid ETF (TXXH) offering leveraged exposure. These funds represent the first U.S. ETFs focused on Hyperliquid, a leading decentralized exchange with signifi…
Evaxion A/S announced that it will present new preclinical data for EVX-04, an AI-designed off-the-shelf therapeutic vaccine targeting endogenous retroviral antigens in acute myeloid leukemia (AML), at the European Hematology Association 2026 Congress. The data demonstrate EVX-04's immune response capabilities and tumor growth prevention in preclin…
Uniti Wholesale has quickly demonstrated strong demand for its FastWaves service, securing a customer for eight 400G circuits just two weeks after launch and delivering circuits in 14 days. FastWaves addresses the market need for faster wavelength delivery, particularly driven by AI workloads, hyperscalers, neocloud providers, and large enterprises…
A senior Pentagon official told lawmakers that U.S. military activity in Iran has reached $29 billion in costs, up $4 billion from an estimate issued in late April. The updated total covers repair and replacement of equipment and operational expenses, but Pentagon officials have not provided a detailed breakdown of the added $4 billion. Lawmakers r…
Futures tied to Canada’s main equity benchmark showed little movement on Tuesday as market participants monitored escalating tensions in the Middle East and fresh U.S. consumer price data. The Toronto market posted a modest gain on Monday led by oil and metals, while U.S. futures were broadly softer as headline and core U.S. CPI came in slightly ab…
AeroVironment received a three-year, $43 million contract from the Department of War Test Resource Management Center to integrate its PANTHER phased array antenna system on DoW SkyRange platforms. The deal is intended to advance airborne telemetry for weapons testing by providing rapidly deployable, multi-target tracking antennas. The company is in…
C3 AI reported preliminary fiscal fourth-quarter revenue of $51.6 million, a 53% year-over-year decline, landing at the high end of its guidance and slightly above consensus. The company posted a narrower-than-expected non-GAAP operating loss, while the pace of new contracts slowed. Founder Thomas M. Siebel returned as CEO in May and said his healt…
